INDV
INDV
NASDAQ · Pharmaceuticals

Indivior Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$28.79
-0.60 (-2.04%)
As of Mar 24, 9:55 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +68.5% upside
Low Target $40.68
Average Target $48.50
High Target $71.11
Current Price $28.79
Current
$28.79
Target
$48.50
$40.68 $48.50 avg $71.11
Scenario Analysis
Bear Case
$40.68
41.3%
Low target
Base Case
$48.50
+68.5%
Avg target
Bull Case
$71.11
+147.0%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$38.00
-24.2% from high
52-Week Low
$8.64
+233.2% from low
50-Day SMA
$34.90
-17.5% vs SMA
200-Day SMA
$24.61
+17.0% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$48.50
+27.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +47.3%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +27.3%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +36.9%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +25.7%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +204.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +81.0%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -20.4%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +819.3%